Risk Factors for Low Lymphocyte Count in Patients With Type 2 Diabetes

Clinical trial NCT01192659 · COMPLETED

Trial details

NCT number: NCT01192659
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Diabetes Mellitus, Type 2

Start date: 2010-05-01
Primary completion: 2015-12-01
Enrollment: 16492

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.